AbbVie Receives European Commission Approval of VENCLYXTO® in Combination with a Hypomethylating Agent for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy Biotech Investing
Bausch Health Announces Participation At The Jefferies Healthcare Conference Medical Device Investing
Bristol Myers Squibb to Host Virtual Investor Event to Discuss ASCO 2021 Highlights Biotech Investing
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives Pharmaceutical Investing
Seelos Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares Psychedelics Investing
EBON, DOX & SHRMF Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
